Skip to main content
. 2014 Apr 9;6(2):19. doi: 10.1186/alzrt249

Figure 3.

Figure 3

Plots illustrating total plasma β-amyloid levels of individual patients by time and dose level. (A) β-amyloid (18–35) Aβ18–35. (B)28–42. GSK: GSK933776. Patients = 6 for each dose group.